chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feeling generally tired; A little achy; Fever/elevated temperature at 100.5; Chills; This is a spontaneous report from a contactable nurse. A 75-year-old male patient receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EL0142), via an unspecified route of administration in the right arm on 18Jan2021 at 10:30 (at the age of 75-years) as a single dose for Covid-19 immunization. Medical history included COVID-19 virus in Dec2020. Prior to the vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. On 18Jan2021 at 20:30, the patient started to have fever / elevated temperature at 100.5 and chills and took paracetamol (TYLENOL). The morning of 19Jan2021, the patient's temperature was 99.6 and he was just feeling generally tired and a little achy. The patient would usually working in the shop early in the morning. On 19Jan2021, the patient was still experiencing side effects until and was also feeling generally tired but was already feeling somewhat better now. The patients most recent temperature was 99.5. The patient's chills had resolved in Jan2021. The clinical outcome of the event chills was recovered in Jan2021, fever was not recovered, tired was recovering, and the outcome of event achy was unknown.
headache; low grade fever; sweats; body aches; hive like rash on both arms in the crevices of my elbow; hive like rash on both arms in the crevices of my elbow; This is a spontaneous report from a contactable Other HCP. This 38-year-old female Other HCP (Patient) reported that:  A 38-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9264), via an unspecified route of administration, administered in Arm Left on 04Feb2021 13:30 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Hypothyroid/hoshimotos, rheumatoid arthritis, asthma, seasonal allergies, IBS, Known allergies: Penicillin. Concomitant medication(s) included ascorbic acid, herbal nos, levoglutamide, lysine, magnesium, manganese, retinol, riboflavin, selenium, tocopherol, zinc (AIRBORNE) taken for an unspecified indication, from unknown start date; levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, from unknown start date; colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for an unspecified indication, from unknown start date, in two weeks. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration, administered in Arm Left on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient previously took amoxicillin and experienced drug hypersensitivity. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. No prior to vaccination. The patient was not tested for COVID-19. On 06Feb2021 23:00, the patient experienced headache, low grade fever, sweats, body aches, hive like rash on both arms in the crevices of my elbow. About 55 hours after receiving vaccination and feeling better from the normal side effects.The patient underwent lab tests and procedures which included investigation: low grade on an unspecified date. No treatment received for the events. The clinical outcome of events were recovered on unspecified date on 2021.  Follow-up attempts completed. No further information expected.
With the first shot I had a sever headache, and very fatigued; With the first shot I had a sever headache, and very fatigued; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Mar2021 08:00 (Lot number: ER8730) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "pencycline" (unspecified if ongoing). Concomitant medication(s) included: SYMBICORT; PROZAC; CLARITIN ALLERGIC; BIOTIN. Past drug history included: Codeine, reaction(s): "Known allergies: codeine"; Sulfur, reaction(s): "Known allergies: sulfur".  The following information was reported: FATIGUE (non-serious), HEADACHE (non-serious) all with onset 2021, outcome "recovering" and all described as "With the first shot I had a sever headache, and very fatigued". Therapeutic measures were not taken as a result of fatigue, headache.  Additional information: It was reported that with the first shot patient had a sever headache, and very fatigued. Other medications in two weeks included symbicort, prozac, claritin, biotin. There were no other vaccine in four weeks. The patient did not had covid prior vaccination. The patient did not tested covid post vaccination. Known allergies included penicillin, codeine, sulfur  No follow-up attempts are possible. No further information is expected.
very red; very frightened; rash at injection site about 2 inches long; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at injection site about 2 inches long). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened). At the time of the report, VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at injection site about 2 inches long). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened). At the time of the report, VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
About 12 hours after receiving the injection, I started having muscle aches and fever and chills.  During the night the muscle aches and fever worsened and I also began to have an intense headache.  The symptoms lasted for about 36 hours and then lessened.  By 48 hours, most symptoms were gone, except for the headache.    I treated the symptoms with acetaminophen and fluids.    These are the same symptoms I had with each Covid-19 shot and also with Covid-19, itself, which I had in November of 2020.
I was not able to climb the 3 stairs to the front of my house by 10 am, getting weaker and weaker every hour. Also losing mental clarity. Awoke at 12:30 am feeling that every cell in my body had frozen; my skin was encasing glaciers of ice that were bumping around each other, causing great pain with every movement. I was surprised to hear myself gasping. I was looking at the scene inside my body. The frozen tension in my body, cell to cell, was crippling. Could not move. I kept appealing to my cells to relax, relax, relieve the tension and the ice would melt.  Despite many down jackets, blankets, heating pad, could not warm. Extreme pain everywhere. Got sicker and sicker throughout the day, (super dizzy), fell twice on my back, fever soared. Fuzzy thinking. Threw up all day Tuesday. Very loose uncontrollable bowel. Friend  who is working here (renovating the apartment) got Tylenol, etc for me. The second time I fell I couldn?t get up and lay on the floor for over an hour until friend reappeared and gently helped me rise and return to couch. I could not even attempt going back to my bed on the other side of the houseand have been in the office couch since Monday evening. Have continued with wearing 2 sweaters, down jacket for the last 24 hours plus blankets and heating pad. Called doc who said this is ?normal? but my condition is much more ?dramatic?. If not better today (Tuesday) to get to emergency, but this am fever is down and I am able to walk a bit. Dizzy headaches and difficulty walking continued for another week and a half. Weakness still evident. Visited doctor Wed March 24 as still had symptoms, dizzy headaches, fuzzy thinking, brain fog, back injury due to falling when extreme dizzy on 16th.
Patient presented to emergency department on  5/11/21 with report of worsening of shortness of breath  and chest pain for previous one week.  Patient reports that she had COVID-19 3 weeks ago and at that time was diagnosed with community acquired pneumonia.  CTA performed in ED noted bilateral pulmonary emboli greater on the right than on the left.  There was an embolus in the right main pulmonary artery with some evidence of right heart strain with RV/LV ratio 1.1  Peripheral ground-glass opacity in right lower lobe also noted.  Patient treated with heparin.  No thrombectomy performed as clot burden had decreased after receiving heparin.  Patient was transitioned to Eliquis and discharged to home.
G62.9 POLYNEUROPATHY 4/26/2022 PERITONEAL CARCINOMATOSIS G62.9 POLYNEUROPATHY 4/26/2022 ADENOCARCINOMA, JEJUNUM G62.9 POLYNEUROPATHY 4/26/2022 JEJUNAL CANCER
Pt recvd series of 3 Engerix-B vax on 0,1,6 mo schedule.Pt devel antibody titers 2-3 mo p/ last dose,"but subsequently tested antibody negative."
his shoulder got a little sore; This is a spontaneous report received from a contactable consumer (patient) via medical information team. A 77-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL9263), via an unspecified route of administration, in the Left arm on 08Feb2021 15:00, as single dose for covid-19 immunization. The patient's medical history included skin cancer, predating treatment with the Pfizer COVID 19 vaccine. Concomitant medications were not reported. On 08Feb2021, the patient's shoulder got a little sore some hours later after the vaccination but it is about back to normal now; he has to raise his arm straight up to even feel it. Caller stated that he received the first dose of the Pfizer covid 19 vaccine on 08Feb2021 and will not be back in the state for the 21-day dosing schedule. Caller wants to know how long he can go and how long can he wait between shots as he will not be back until 04Mar2021 which is longer than 21 days from his first dose. They advised him he could wait 6 weeks maximum and no more. On or after 08Mar2021, the patient was planning to get the second dose. The outcome of event was recovering.
Patient reports starting about a week after vaccine, "i felt exhausted, couldn't move, wanted to lay down and fall asleep, decreased appetite and thirst, half of my face on left side and the rest of my left side of my body was numb, and every day worse and worse, this has stayed the same." "hand hurt real bad."
Patient received first Pfizer covid vaccine from our vaccine clinic on 8/24/21. We later determined that she had received one Moderna dose on 5/5/21.
Muscle Pain/ he could not get out of bed; Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle Pain/ he could not get out of bed) and ARTHRALGIA (Joint Pain) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 032620A) for COVID-19 vaccination.     Concomitant products included INSULIN GLARGINE (LANTUS), METFORMIN, ATORVASTATIN, LISINOPRIL, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), ACETYLSALICYLIC ACID (BABY ASPIRIN) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced MYALGIA (Muscle Pain/ he could not get out of bed) and ARTHRALGIA (Joint Pain). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle Pain/ he could not get out of bed) and ARTHRALGIA (Joint Pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-240177 (Patient Link).
Ggradual onset of sneezing and throat irritation that began 15 minutes after vaccination. Has progressed to the need to clear throat constantly.
Facial swelling of lips and cheek; hives/welts on chest, neck and face; lower right abdominal pain; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old non-pregnant female patient received bnt162b2 (BNT162B2) formulation solution for injection, dose 1 (Lot Number: EN6208 expiry date was unknown) via an unspecified route of administration at arm left on 12Mar2021 13:00 (at the age of 46-years-old) as a single for covid-19 immunisation. Medical history included blood pressure abnormal from an unknown date and unknown if ongoing, blood cholesterol abnormal from an unknown date and unknown if ongoing, hypertonic bladder from an unknown date and unknown if ongoing, intestinal angioedema from an unknown date and unknown if ongoing. Concomitant medication(s) included oxybutynin taken for an unspecified indication, hydralazine, amitriptyline levonorgestrel. Known allergies: Lisinopril, atenolol, nuvaring, Procardia, voltaren. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Other medications in two weeks: oxybutynin, hydralazine, amitriptyline, Mirena IUD. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 12Mar2021 13:30 the patient experienced Facial swelling of lips and cheek, hives/welts on chest, neck and face, lower right abdominal pain. Adverse events treatment- 2-epinephrine, famotidine, fentanyl, Methylprednisolone. Outcome of the events was recovering.    No follow-up attempts are possible. No further information is expected.
This is a spontaneous case, initially received from physician on 30-Oct-2018, concerning a female patient of unspecified age. It was reported that there was a first time temperature excursion with MDV for two hours, which reached to maximum temperature 34 F. On an unspecified date, the patient administered FLUCELVAX (QIV) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252225 and expiry date: 31-May-2019] which underwent temperature excursion. The patient did not experience any adverse events after vaccination. The reporter assessed the case non-serious.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Reporter stated that no adverse reactions were reported by any patients.
This spontaneous report was received from a medical assistant refers to a patient of unknown age. On 03-MAR-2016, the patient was vaccinated with GARDASIL dose 1. On 29-JUL-2016, the patient was vaccinated with GARDASIL dose 2 later than the recommended schedule. On 28-SEP-2016, the patient was in the office to receive GARDASIL dose 3 earlier than the recommended schedule. No adverse effects were reported. Additional information has been requested.
Patient felt faint went to sit down, but then fell from the seat. We moved him to the floor and placed him on his side. He was clammy but said he felt hot. Paramedics were called and arrived within 5 mins, then transported him to hospital
Gave it under the shoulder blade instead of the shoulder; Hurt when they gave her the injection/ still having a lot of pain; Couldn't raise her arm/ raise her arm a little; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration under the shoulder blade on 04Jun2019 at single dose for immunization. The patient's medical history and concomitant medications were not reported. It was recommended by her doctor to get the pneumococcal 13-val conj vac (dipht crm197 protein) injection so she got it on 04Jun2019 and they gave it under the shoulder blade instead of the shoulder and it hurt when they gave her the injection. She couldn't raise her arm at all on 04Jun2019 and was still having a lot of pain and can only raise her arm a little. She was concerned about it because she didn't think it was given in the right spot. The outcome of the events was unknown.
Muscle in left arm has become gradually weaker with pain on lifting arm/ turning clockwise.  Pain radiates down upper arm muscle to forearm muscle to wrist.
Patient called today 10/5/13 to report extreme fatigue which started today (2 days after injection). No other symptoms just fatigue. Advised contact primary care MD to consult w/ MD.
Started noticing arthritic type pain.  I have had a meniscus tear ongoing for about three years in my right knee, but the knee started hurting a lot worse, achey, not what I'd been feeling, along with my fingers feeling stiff and painful, right shoulder feeling stiff and painful,  left knee feeling swollen and achey,
Red blotchy rash on arms, stomach, buttocks and legs. Patient experienced chills but no fever.
My first adverse reaction was when I went home for a trip to the country in February 2022. I was a the beach and my daughter very lightly hit my the top of my foot with her plastic shovel. I was instantly cut and started to bleed something I thought was strange and cannot remember happening before. Subsequently my short term memory isn't as sharp, I have neuropathy/ numbness/ tingling in mm feet mainly toes, intermittent swelling in feet, erectile dysfunctions issues. I didn't have any of theses problems before I got boosted.
Pt developed high pitched screams that we could not stop; stopped smiling; didn't move around as much. All occurred in 1st week after shots. Within three weeks, seizures and severe brain damage. Loss of head control and ability to suck bottle.
I felt a little lightheaded about 5 min after receiving injection, but thought it was because I hadn't eaten that much earlier in the day and it was dinner time. Stayed in observation area for 20 min with no changes. 10-15 min into my drive home started to feel like the back of my throat was scratchy and slightly numb. Had the sensation that a cholresceptic spray had numbed the back of my throat. A few minutes later the numbness spread to my tongue and then lower lip. I never experienced trouble breathing or swelling or rash. I meet up with some nursing/paramedic friends. I took 50mg of benadryl and a pepcid tab both orally.  My symptoms didn't worsen and seemed to have resolved when I woke up this morning around 6 am.
Patient developed a painful rash to left deltoid area 2 days after receiving vaccination. Seen in urgent care on 5/28 and seen by PCP on 5/29. Patient diagnosed with herpes zoster at site of injection with active blisters covering Lt deltoid and scattered clusters down to dorsum on Lt hand. Pt treated with Valacyclovir, Lidocaine patch, Tramadol and now referred to pain management. Rash is subsiding however pain continues.
Pt awoke aphasic, unsteady gait, confused.  Contacted neighbor.  EMS arrived, transported to stroke center.  Elapsed time from stroke s/s to ED was apx 2 hrs. CT positive for very recent CVA and additional previous CVA one opposite hemisphere.  unable to determine age of  first (older) CVA.  Pt was unaware of first CVA.